Status:

COMPLETED

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

Lead Sponsor:

Brooke Army Medical Center

Conditions:

Mild Traumatic Brain Injury

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The administration of N-acetyl-cysteine (an anti-oxidant) for seven days along with observation will result in improved hearing and balance function in individuals who demonstrate these disorders afte...

Detailed Description

5.0 RESEARCH PLAN: The goal of this study is to examine the use of one anti-oxidant, N acetylcysteine (NAC), in individuals who suffer blast injury and demonstrate early sequela of mTBI. Recent chang...

Eligibility Criteria

Inclusion

  • Be active duty United States Service member
  • Be between the ages of 18 and 50 years
  • Present to TQ Surgical within 24 hours of blast exposure.
  • Have complains consistent with possible TBI including hearing loss, dizziness, lightheadedness, cognitive difficulties, and/or had loss of consciousness.
  • Are not expressly excluded by the criteria listed below.

Exclusion

  • Require urgent or emergent surgical procedures.
  • Will require medical evacuation to any level III or higher facility (other then to a level III for a CT scan only).
  • Has evidence of an open head wound.
  • Pregnant Females
  • The use, within the last seven days, of a nutritional supplement containing an anti-oxidant.

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2009

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00822263

Start Date

November 1 2008

End Date

August 1 2009

Last Update

August 10 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

TQ Surgical

AL Taqaddum, Iraq

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure | DecenTrialz